![John Osth](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John Osth
Director Ejecutivo en QuantumCor, Inc. .
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Mitchell R. Stoller | M | - |
The Marrow Foundation
| 17 años |
Howard J. Kerr | M | 89 |
The Marrow Foundation
| - |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Geri Sands Hansen | F | - |
The University of Chicago
| 4 años |
Todd Eugene Petzel | M | - |
The University of Chicago
| 7 años |
Brady Dougan | M | 64 |
The University of Chicago
| 5 años |
Michael Anthony Duffy | M | - |
The University of Chicago
| 8 años |
Mary Patricia Quinn | F | - |
The University of Chicago
| 5 años |
Victor Canto | M | - |
The University of Chicago
| 5 años |
Audrey Lew | F | 59 |
Chemokine Therapeutics Corp.
![]() Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | 2 años |
Kevin K. Pfeffer | M | - |
The University of Chicago
| 6 años |
Mauricio Antonio González Gómez | M | - |
The University of Chicago
| 3 años |
George K. Hersh | M | - |
The University of Chicago
| 6 años |
Kai Kuo Chao | M | - |
The University of Chicago
| 3 años |
Theo Vermaelen | M | 70 |
The University of Chicago
| 6 años |
Charles Frederick Pohl | M | - |
The University of Chicago
| 5 años |
Hassan Salari | M | 69 |
Chemokine Therapeutics Corp.
![]() Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | 9 años |
Dennis Joseph McNamara | M | 70 |
The University of Chicago
| 7 años |
Bashir Jaffer | M | 76 |
Chemokine Therapeutics Corp.
![]() Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | 2 años |
Stu J. Sweet | M | - |
The University of Chicago
| 6 años |
Tibor D. Klopfer | M | - |
The University of Chicago
| 3 años |
Scott E. Pickens | M | - |
The University of Chicago
| 2 años |
Steven Shebik | M | 67 |
The University of Chicago
| 2 años |
David Guilmette | M | 61 |
The University of Chicago
| 4 años |
David Wagener | M | 69 |
The University of Chicago
| 2 años |
Mike S. Gilman | M | - |
The University of Chicago
| 2 años |
Paul Alivisatos | M | - |
The University of Chicago
| 4 años |
William S. Dorson | M | - |
The University of Chicago
| 2 años |
Dominic C. Yang | M | - |
The University of Chicago
| 4 años |
Richard Straube | M | 72 |
The University of Chicago
| 3 años |
Alice Peters | F | - |
The University of Chicago
| 1 años |
Preston L. C. Johnson | M | - |
The University of Chicago
| 2 años |
Ezra Katzen | M | 70 |
The University of Chicago
| 3 años |
Joseph W. Hill | M | - |
The University of Chicago
| 2 años |
Robert j. Minkus | M | - |
The University of Chicago
| 3 años |
John Baily | M | 80 |
The University of Chicago
| 2 años |
Wutisak Lapcharoensap | M | 76 |
The University of Chicago
| 1 años |
Kathleen West | F | - |
The University of Chicago
| 3 años |
Gordon Hamilton | M | 68 |
The University of Chicago
| 4 años |
Jose Luiz Alqueres | M | 80 |
The University of Chicago
| 1 años |
Cheryl Spielman | F | 69 |
The University of Chicago
| 2 años |
Cheuk Fai Kam | M | 70 |
The University of Chicago
| 2 años |
Hemant Kamala Jalan | M | 66 |
The University of Chicago
| 2 años |
Paulo Guedes | M | 73 |
The University of Chicago
| 3 años |
Thomas H. Hopkins | M | - |
The University of Chicago
| 4 años |
Stephen R. Daniels | M | - |
The University of Chicago
| 3 años |
Christopher K. Zarins | M | - |
The University of Chicago
| 15 años |
Jerry Swiss | M | - |
The University of Chicago
| 1 años |
Jake Leong Wong | M | 63 |
The University of Chicago
| 4 años |
Andy R. Stern | M | - |
The University of Chicago
| 3 años |
Nehme Sabbagh | M | 73 |
The University of Chicago
| 1 años |
Jay Cohen | M | - |
The University of Chicago
| 3 años |
A. G. Malliaris | M | - |
The University of Chicago
| 3 años |
James D. Alt | M | 73 |
The University of Chicago
| 3 años |
Marcia de Wachter | M | 70 |
The University of Chicago
| 1 años |
Mark Edward Hunt | M | 63 |
The University of Chicago
| 4 años |
Mitchell Glass | M | - |
The University of Chicago
| 4 años |
Mark Alan Abeshouse | M | - |
The University of Chicago
| 2 años |
David Elliot Eisenbud | M | - |
The University of Chicago
| 1 años |
David E. Storto | M | - |
The University of Chicago
| 1 años |
Spencer Lee | M | 68 |
The University of Chicago
| 2 años |
Mohammad Azab | M | 68 |
Chemokine Therapeutics Corp.
![]() Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | 1 años |
Michael Kubacki | M | 72 |
The University of Chicago
| 2 años |
David J. Steirman | M | - |
The University of Chicago
| 2 años |
Kumar Kirpalani | M | - |
The University of Chicago
| 22 años |
Harold Jay Levy | M | 70 |
The University of Chicago
| 2 años |
John Prann | M | 73 |
The University of Chicago
| 2 años |
Dennis Ward Stattman | M | - |
The University of Chicago
| 2 años |
Paul Hutchison Saunders | M | - |
The University of Chicago
| 2 años |
Vicki Avril-Groves | F | 69 |
The University of Chicago
| 3 años |
Venetia Gerasimou Kontogouri | F | 72 |
The University of Chicago
| 2 años |
Paul S. Fisher | M | 68 |
The University of Chicago
| 3 años |
Peter Browning | M | 83 |
The University of Chicago
| 2 años |
Timothy Hoeksema | M | 77 |
The University of Chicago
| 2 años |
Richard M. Gunst | M | 68 |
The University of Chicago
| 2 años |
Marcel Fournier | M | 69 |
The University of Chicago
| 2 años |
Paul N. Harris | M | 65 |
The University of Chicago
| 4 años |
John A. Salvette | M | 67 |
The University of Chicago
| 2 años |
Rick Timmons | M | 72 |
The University of Chicago
| 1 años |
Daniel P. Reingold | M | - |
The University of Chicago
| 1 años |
Lourdes Josephine Gotianun-Yap | F | 69 |
The University of Chicago
| 2 años |
Esther M. Stearns | F | - |
The University of Chicago
| 3 años |
Peter Brennan | M | 69 |
The University of Chicago
| 2 años |
Kevin Connelly | M | 71 |
The University of Chicago
| 2 años |
Jim Koch | M | - |
The University of Chicago
| 3 años |
Stephen Timothy Kochis | M | - |
The University of Chicago
| 2 años |
Robert B. Stearns | M | 71 |
The University of Chicago
| 2 años |
Glenn M. Engelmann | M | - |
The University of Chicago
| 3 años |
J. Stephen Vanderwoude | M | 80 |
The University of Chicago
| 2 años |
Marc Bergschneider | M | - |
The University of Chicago
| 2 años |
Peter M. Bonutti | M | - |
The University of Chicago
| 4 años |
Jay Nelson Mueller | M | - |
The University of Chicago
| 4 años |
John J. Studzinski | M | - |
The University of Chicago
| 2 años |
Glen C. Laschober | M | 70 |
The University of Chicago
| 2 años |
Cadmus Metcalf Hicks | M | - |
The University of Chicago
| 2 años |
Peter Wolfgang Hegel | M | - |
The University of Chicago
| 2 años |
John M. Goense | M | - |
The University of Chicago
| 4 años |
John E. Brower | M | - |
The University of Chicago
| 4 años |
Peter Hirsch | M | - |
The University of Chicago
| 4 años |
Daniel Zaldivar | M | - |
The University of Chicago
| 4 años |
Gary Byram | M | - |
The University of Chicago
| 5 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 96 | 96.00% |
Canadá | 4 | 4.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- John Osth
- Red Personal